PM-54

N/A

Report date: 2025/06/19 11:38:51
NME

Base Information

Drug NamePM-54
Drug Alias NamePM-54
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA polymerase II inhibitors
TargetsRNA polymerase II
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesPharma Mar Sa
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A